Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Inc. (GALT) is a healthcare company (biotechnology) based in the United States. The share price is $2.91, down 3.64% on the day, which values the company at $293.47M. Price as of 18 Nov 2026, 11:56 UTC, from Yahoo Finance.

Key facts

Share price
$2.91−3.64% today
Market value
$293.47M
200-week average
$2.5912% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Galectin Therapeutics Inc. in more detail

GALT trades at -1.7× next year's expected earnings. It sits 12% above its 200-week average of $2.59.

Worth checking: Weak Piotroski score; Share count keeps rising.

Galectin Therapeutics Inc. (GALT): questions and answers

What is GALT's PEG ratio?

Galectin Therapeutics Inc.'s PEG ratio is -36.15 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Galectin Therapeutics Inc.'s market cap?

Galectin Therapeutics Inc. is valued at $293.47M at a share price of $2.91.

Is GALT above its 200-week moving average?

Yes. GALT is 12.2% above its 200-week average of $2.59. Long-term investors watch that line because strong companies rarely trade below it for long.

Does GALT pay a dividend?

Galectin Therapeutics Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Galectin Therapeutics Inc. (GALT) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/GALT

Underlying data: Yahoo Finance; company filings with the SEC.